Rationale for a Trial of Low-Dose Aspirin for the Primary Prevention of Major Adverse Cardiovascular Events and Vascular Dementia in the Elderly

M. Nelson,C. Reid,L. Beilin,G. Donnan,C. Johnston,H. Krum,E. Storey,A. Tonkin,J. McNeil
DOI: https://doi.org/10.2165/00002512-200320120-00004
Drugs & Aging
Abstract:
What problem does this paper attempt to address?